PMID- 23360252
OWN - NLM
STAT- MEDLINE
DCOM- 20131119
LR  - 20191112
IS  - 2212-4055 (Electronic)
IS  - 1871-5281 (Linking)
VI  - 12
IP  - 2
DP  - 2013 Apr
TI  - Intravenous immunoglobulin therapy in dermatology: an update.
PG  - 132-46
AB  - Intravenous immunoglobulin (IVIG) is a fractioned blood product consisting of IgG 
      antibodies which was first used in antibody deficiency disorders. It is 
      increasingly being used for several inflammatory and autoimmune conditions. IVIG 
      can also be used in a wide range of dermatological diseases which are difficult 
      to treat including autoimmune bullous skin diseases and toxic epidermal 
      necrolysis. The use of IVIG in dermatological disorders is discussed in this 
      article.
FAU - Cakmak, Seray Kulcu
AU  - Cakmak SK
AD  - Ankara Numune Education and Research Hospital, Dermatology Clinic, and Ankara 
      University, Faculty of Medicine, General Surgery Department, 701, sok 18/8 Y ld z 
      Cankaya, Ankara, Turkey. seraycakmak@yahoo.com
FAU - Cakmak, At l
AU  - Cakmak Al
FAU - Gonul, Muzeyyen
AU  - Gonul M
FAU - K l c, Arzu
AU  - K l c A
FAU - Gul, Ulker
AU  - Gul U
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United Arab Emirates
TA  - Inflamm Allergy Drug Targets
JT  - Inflammation & allergy drug targets
JID - 101266886
RN  - 0 (Immunoglobulins, Intravenous)
SB  - IM
MH  - Dermatology/methods
MH  - Humans
MH  - Immunization, Passive/*methods
MH  - Immunoglobulins, Intravenous/*administration & dosage
MH  - Skin Diseases/*drug therapy
EDAT- 2013/01/31 06:00
MHDA- 2013/11/20 06:00
CRDT- 2013/01/31 06:00
PHST- 2012/12/27 00:00 [received]
PHST- 2013/01/15 00:00 [revised]
PHST- 2012/01/21 00:00 [accepted]
PHST- 2013/01/31 06:00 [entrez]
PHST- 2013/01/31 06:00 [pubmed]
PHST- 2013/11/20 06:00 [medline]
AID - CDTIA-EPUB-20130122-3 [pii]
AID - 10.2174/1871528111312020007 [doi]
PST - ppublish
SO  - Inflamm Allergy Drug Targets. 2013 Apr;12(2):132-46. doi: 
      10.2174/1871528111312020007.